Filing Details
- Accession Number:
- 0001179110-15-003056
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-20 16:42:56
- Reporting Period:
- 2015-02-18
- Filing Date:
- 2015-02-20
- Accepted Time:
- 2015-02-20 16:42:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1065087 | Albany Molecular Research Inc | AMRI | Services-Commercial Physical & Biological Research (8731) | 141742717 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1449207 | R Steven Hagen | 26 Corporate Circle Albany NY 12203 | Svp Pharmaceutical Dev & Mfg | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-02-18 | 1,623 | $16.48 | 25,091 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-02-18 | 3,750 | $2.93 | 28,841 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-02-18 | 3,750 | $16.60 | 25,091 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-02-18 | 1,250 | $2.93 | 26,341 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-02-18 | 1,250 | $16.46 | 25,091 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option to Purchase Common Stock | Acquisiton | 2015-02-18 | 5,000 | $2.93 | 5,000 | $2.93 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,500 | 2022-02-17 | No | 4 | M | Direct |
Footnotes
- 50% of grant is time based and 50% is performance based. Time based grant vests 25% per year on each of the first 4 anniversaries of the date of grant (February 17, 2012). Performance based grant vests 25% per year on each of the first 4 anniversaries of the grant date if (1) certain performance criteria related to the Company's operating profitability are reached and (2) the grantee is employed on such anniversary date; if the foregoing criteria are not met on any anniversary date, 25% of the shares of options under the performance award will immediately be forfeited. The 5,000 shares being exercised represent a portion of the vested grant.
Billionaire Hedge Funds
